Immune deposits in the dermo-epidermal junction in rheumatoid arthritis.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 322268)

Published in Scand J Rheumatol on January 01, 1977

Authors

R Donde, H Permin, F Juhl, A Wiik, N E Hansen, R B Andersen

Articles by these authors

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31

Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29

Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85

Lysozyme turnover in the rat. J Clin Invest (1971) 1.78

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73

[Chronic fatigue syndrome--a defined unity?]. Ugeskr Laeger (1994) 1.71

Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64

Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64

Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy (1980) 1.59

Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS (1999) 1.58

Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy. Br J Haematol (1993) 1.55

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51

Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49

Quantitative and qualitative estimations of IgE bound to basophil leukocytes from hay fever patients. Scand J Immunol (1977) 1.45

Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol (1995) 1.45

The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol (1996) 1.45

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41

[Growing pains of cochranology]. Ugeskr Laeger (1999) 1.38

Traffic casualties. I. Physical and social sequelae: a follow-up of 3000 traffic accidents. Dan Med Bull (1972) 1.38

Fibrinolytic and fibrin stabilizing activity of synovial membranes. Ann Rheum Dis (1970) 1.36

Lysozyme turnover in man. J Clin Invest (1972) 1.33

BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis (1994) 1.25

Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol (1983) 1.25

Trends in the incidence of leukemia in Denmark, 1943-77: an epidemiologic study of 14,000 patients. J Natl Cancer Inst (1983) 1.22

Persistent local cutaneous atrophy following corticosteroid injection for tendinitis. Rheumatol Rehabil (1979) 1.16

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur J Biochem (1992) 1.15

Different molecular forms of fibronectin in rheumatoid synovial fluid. Arthritis Rheum (1982) 1.14

Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis (1975) 1.13

Intrinsic asthma and bacterial histamine release via lectin effect. Agents Actions (1983) 1.11

The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood (1994) 1.11

Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand (1982) 1.10

Immunological studies in two children with recurrent parotitis. Acta Paediatr Scand (1983) 1.10

Antinuclear factors in sera from healthy blood donors. Acta Pathol Microbiol Scand C (1976) 1.09

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08

[Chronic fatigue syndrome--a controlled cross-sectional study]. Ugeskr Laeger (1994) 1.08

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (1995) 1.08

Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study. Am J Clin Pathol (1994) 1.07

Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid. Arthritis Rheum (1983) 1.07

Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis (1974) 1.06

Anti-neutrophil cytoplasm antibodies 1988. Lancet (1988) 1.06

Regional muscle tension and pain ("fibrositis"). Effect of massage on myoglobin in plasma. Scand J Rehabil Med (1983) 1.06

Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis (1990) 1.05

Autoantibodies in serum and sputum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C (1979) 1.05

Tenosteochondrosis of the pubis. Acta Rheumatol Scand (1969) 1.05

Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics. Acta Med Scand (1975) 1.04

Muramidase activity of bone marrow plasma. Studies in haematologically normal individuals and in granulocytopenic patients. Acta Med Scand (1969) 1.04

Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol (1998) 1.04

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) (2003) 1.04

The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood (1992) 1.03

Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol (1995) 1.03

Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int (1998) 1.03

Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol (1999) 1.03

Bacterial histamine release by immunological and non-immunological lectin-mediated reactions. Allergy (1984) 1.02

Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol (1999) 1.02

Receptor binding of lactoferrin by human monocytes. Br J Haematol (1983) 1.02

Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol (2004) 1.02

High-affinity binding sites for prostaglandin E on human lymphocytes. Cell Immunol (1979) 1.01

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol (1994) 1.01

Humoral and cellular immunity in sarcoidosis. Acta Med Scand (1978) 1.01

Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant (1997) 1.00

Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody. Trans R Soc Trop Med Hyg (1997) 1.00

Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun (1988) 0.99

Hypercalcaemia in the accelerated phase of chronic myelogenous leukaemia: no relationship to the phenotype of the blast cells. Scand J Haematol (1985) 0.99

Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol (2001) 0.99

Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease. Acta Pathol Microbiol Immunol Scand C (1983) 0.99

Circulating autoantibodies in patients with acute viral hepatitis. Relation to etiology and clinical course. Scand J Gastroenterol (1980) 0.99

Demonstration of electrophoretic heterogeneity of serum beta 2-microglobulin in systemic lupus erythematosus and rheumatoid arthritis: evidence against autoantibodies to beta 2-microglobulin. Scand J Immunol (1979) 0.98

Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS Suppl (1989) 0.98

Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun (1999) 0.97

Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors. Immunology (1972) 0.97

Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Methods (1994) 0.97

IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97

Neutrophilic granulocytes in acute bacterial infection. Sequential studies on lysozyme, myeloperoxidase and lactoferrin. Clin Exp Immunol (1976) 0.97

Immunological studies in sarcoidosis: a comparison of disease activity and various immunological parameters. Ann N Y Acad Sci (1976) 0.96

High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases. Clin Exp Immunol (1986) 0.95

An approach to the diagnosis and management of systemic vasculitis. Clin Exp Immunol (2010) 0.95

Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies. Acta Derm Venereol (1974) 0.95

Plasma lysozyme--a measure of neutrophil turnover. An analytical review. Ser Haematol (1974) 0.94

Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis. J Antimicrob Chemother (1983) 0.94

Sequential studies of lymphocyte responsiveness and antibody formation in acute bacterial meningitis. Clin Exp Immunol (1976) 0.94

Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis. Acta Paediatr Scand (1983) 0.94

Plasma lysozyme in drug-induced and spontaneous cyclic neutropenia. Br J Haematol (1973) 0.93

Immune complexes in cystic fibrosis. Acta Pathol Microbiol Scand C (1977) 0.93

Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study. Arthritis Rheum (1971) 0.93

Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). Scand J Rheumatol (1979) 0.93

Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis (2001) 0.93

Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity--a methodological study. J Immunol Methods (1995) 0.93

Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis. Immunology (1974) 0.92

Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol (1997) 0.92

Monoclonal immunoglobulinaemia associated with glomerulopathy. Acta Med Scand (1975) 0.92

The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. Clin Exp Immunol (1989) 0.92

Possible role of histamine in rheumatoid arthritis. Treatment with cimetidine and mepyramine. Allergy (1981) 0.92